A quest for therapeutic antigens in bone and soft tissue sarcoma
- PMID: 16086842
- PMCID: PMC1188080
- DOI: 10.1186/1479-5876-3-31
A quest for therapeutic antigens in bone and soft tissue sarcoma
Abstract
Over the past three decades, there have been remarkable advances in the treatment of bone and soft tissue sarcomas. These include the introduction of adjuvant chemotherapy, establishment of guidelines for adequate surgical margins, and the development of post-excision reconstruction. There have also been advances in the field of immunotherapy against bone and soft tissue sarcomas, which, unfortunately, have received less attention. However, lack of progress in chemotherapy-based treatments for bone and soft tissue sarcomas has reignited interest in immunotherapeutic approaches. Here we summarize current progress in the immunotherapy of bone and soft tissue sarcomas including the strategies utilized to identify tumor-associated antigens, and the design of clinical trials.
Figures
References
-
- Fletcher CDM, Rydholm A, Singer S, Sundaram M, Coindre JM. Soft tissue tumorus: Epidemiology, clinical features, histopathological typing and grading. In: Fletcher CDM, Unni KK, Mertens F, editor. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. pp. 12–18.
-
- Dorfman HD, Czerniak B, Kotz R, Vanel D, Park YK, Unni KK. WHO classification of tumours of bone: Introduction. In: Fletcher CDM, Unni KK, Mertens F, editor. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. pp. 227–232.
-
- Campbell CJ, Cohen J, Enneking WF. New therapies for osteogenic sarcoma. J Bone Joint Surg Am. 1975;57:143–144. - PubMed
-
- Marcove RC, Mike V, Huvos AG, Southam CM, Levin AG. Vaccine trials for osteogenic sarcoma. A preliminary report. CA Cancer J Clin. 1973;23:74–80. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
